Medpace (MEDP) Financial Analysis & Valuation | Quarter Chart

Medpace (MEDP)

MEDP
Price: $393.42
Fair Value: 🔒
🔒score
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical... more
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services... more
Description Shares
Market Cap$11.24BExchangeNASDAQ
SectorHealthcareIndustryMedical - Diagnostics & Research
CountryUSCEOAugust James Troendle
IPO Date2016-08-11CAGR0.2%
Employees5,900Websitewww.medpace.com
Div. Yield—Payout Ratio—
Buy Back Yield4.86%Total Yield4.86%
MEDP chart loading...
Fundamentals Technicals
Enterprise Value$13.13BP/E Ratio29.18
Forward P/E22.49PEG Ratio1.58
P/S Ratio4.19P/B Ratio18.7
P/CF Ratio15.14P/FCF Ratio15.09
EPS$15.3EPS Growth 1Y21.53%
EPS Growth 3Y101.77%EPS Growth 5Y278.15%
Revenue Growth 1Y24.19%Gross Margin0.29%
Operating Margin0.21%Profit Margin0.17%
ROE1.21%ROA0.22%
ROCE0.72%Current Ratio0.85
Quick Ratio0.85Cash Ratio0.49
Debt/Equity0.2Interest Coverage—
Altman Z Score6.21Piotroski Score7

View Medpace financial charts →